| Dec 31,
2011 | Dec 31,
2012 | Dec 31,
2013 | Dec 31,
2014 | Dec 31,
2015 | Dec 31,
2017 | Dec 31,
2018 | Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 | Dec 31,
2024 |
|---|
| Net (loss) income | - | - | - | - | - | - | - | - | -28 | 19 | -3 | -32 |
|---|
| Depletion, depreciation and accretion | - | 90 | 464 | 534 | 364 | 110 | 78 | 62 | 45 | 52 | 57 | 53 |
|---|
| Impairment of contract asset | - | - | - | - | - | - | - | - | - | - | - | 19 |
|---|
| Share-based Compensation | 4 | 5 | 17 | 19 | 15 | 37 | 15 | 3 | 2 | 2 | -1 | 0 |
|---|
| Unrealized gain on derivative contracts | - | - | - | - | - | - | - | -6 | -48 | 20 | 22 | 11 |
|---|
| Amortization of Financing Costs | - | 6 | 3 | 4 | 7 | 2 | 1 | - | 0 | 5 | 8 | 6 |
|---|
| Loss (gain) on extinguishment of debt | - | - | - | - | 762 | -115 | - | - | 2 | - | - | -7 |
|---|
| Accrued settlements on derivative contracts | - | - | - | - | - | - | - | - | 7 | 4 | 0 | 0 |
|---|
| Change in fair value of embedded derivative liability | - | - | - | - | - | - | - | - | - | 2 | 2 | 2 |
|---|
| Other expense (income) | -0 | 0 | -1 | 2 | -9 | 3 | 2 | -0 | 1 | 0 | -0 | -0 |
|---|
| Accounts receivable | -0 | 93 | 96 | -86 | -86 | -103 | -0 | -14 | 5 | -1 | -16 | 3 |
|---|
| Prepaids and other | 0 | 1 | 9 | -7 | -4 | 4 | -6 | -5 | -1 | -0 | -0 | 0 |
|---|
| Accounts payable and accrued liabilities | - | 156 | 42 | -40 | -53 | -78 | 22 | -18 | 1 | 18 | -35 | -3 |
|---|
| Net cash provided by operating activities | 30 | 118 | 494 | 668 | 467 | 115 | 67 | 50 | 69 | 79 | 18 | 35 |
|---|
| Oil and natural gas capital expenditures | - | 1,217 | 2,380 | 1,524 | 659 | 331 | 476 | 102 | 53 | 125 | 46 | 65 |
|---|
| Proceeds received from sales of oil and natural gas assets | - | - | - | - | - | - | - | 29 | 1 | 0 | 5 | 7 |
|---|
| Acquisition of oil and natural gas properties | - | - | - | - | - | - | - | 0 | - | - | - | 0 |
|---|
| Other operating property and equipment capital expenditures | - | - | - | - | - | - | - | 0 | 0 | 1 | 0 | 0 |
|---|
| Contract asset | - | - | - | - | - | - | - | - | - | - | 10 | 8 |
|---|
| Other | - | - | -3 | -2 | -2 | -1 | -0 | -1 | -0 | -0 | 0 | 0 |
|---|
| Net cash used in investing activities | -25 | -2,866 | -2,101 | -1,271 | -667 | 599 | -706 | -72 | -52 | -126 | -52 | -65 |
|---|
| Proceeds from borrowings | 250 | 2,467 | 3,725 | 2,276 | 1,834 | 1,349 | 438 | 148 | 374 | 35 | - | 162 |
|---|
| Repayments of borrowings | 246 | 655 | 2,644 | 1,719 | 1,644 | 1,923 | 232 | 132 | 332 | 0 | 35 | 200 |
|---|
| Payment of debt financing costs | 8 | - | - | - | - | - | - | - | - | - | - | - |
|---|
| Payment of deferred financing costs | - | 53 | 24 | 1 | 30 | 18 | 4 | - | 14 | 3 | - | 8 |
|---|
| Proceeds from issuance of preferred stock | - | - | - | - | - | 400 | - | - | - | - | 95 | 39 |
|---|
| Other | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | - |
|---|
| Net cash (used in) provided by financing activities | -4 | 2,751 | 1,607 | 644 | 164 | -289 | 262 | 16 | 27 | 32 | 59 | -8 |
|---|
| Net increase (decrease) in cash, cash equivalents and restricted cash | - | - | - | - | - | - | - | -6 | 44 | -16 | 25 | -38 |
|---|
| Interest Paid, Net | - | - | - | - | - | 91 | 38 | 8 | - | - | 29 | 22 |
|---|
| Asset retirement obligations | - | - | - | - | - | - | - | -1 | 1 | 4 | 1 | 1 |
|---|
| Capital expenditures in accrued liabilities and accounts payable | - | - | - | - | - | - | - | - | - | - | - | 8 |
|---|
| Liabilities Assumed | - | - | - | - | - | - | - | - | - | - | 5 | - |
|---|
| Deemed dividends on Series A preferred stock | - | - | - | - | - | - | - | - | - | - | 12 | 32 |
|---|
| Accrued offering costs | - | - | - | - | - | - | - | - | - | - | -0 | - |
|---|